权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Tumor suppressor reprogramming by EBV through post-translational modification

EBV 通过翻译后修饰重编程肿瘤抑制因子

基本信息

批准号：
10402055
负责人：
ERLE S. ROBERTSON
金额：
$ 53.94万
依托单位：
UNIVERSITY OF PENNSYLVANIA
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-09-01 至 2027-08-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10402055
关键词：
AIDS-Related Lymphoma Acetylation Acetyltransferase Acquired Immunodeficiency Syndrome Affect Automobile Driving B Cell Proliferation B lymphocyte immortalization B-Cell Lymphomas B-Lymphocytes Binding Biochemical Burkitt Lymphoma Cell Cycle Cell Cycle Progression Cell Cycle Regulation Cell Survival Cell model Cells Complex Cyclin D1 Cyclins DNA Damage Degradation Pathway Disease E2F transcription factors Epstein-Barr Virus Infections Epstein-Barr Virus latency Escherichia coli Family Family member Gene Expression Genes Genetic Transcription Genome Goals HIV HIV Seropositivity Hodgkin Disease Human Human Herpesvirus 4 Human Herpesvirus 8 Human Papillomavirus Immune Immunocompromised Host In Vitro Individual Infection Intervention Knock-out Knowledge Lead Link Lymphoma Malignant - descriptor Malignant Neoplasms Mammalian Cell Mediating Modeling Modification Molecular Molecular Biology Molecular Genetics Mutate Non-Hodgkin&apos s Lymphoma Nuclear Antigens Nuclear Protein Oncogenes Oncogenic Oncogenic Viruses Pathology Pathway interactions Patients Phenotype Phosphorylation Phosphotransferases Polyomavirus Post-Translational Protein Processing Proteins Recombinants Regulation Repressor Proteins Retinoblastoma Protein Role Site Testing Therapeutic Intervention Transcription Repressor Translations Tumor Suppressor Proteins Ubiquitination Untranslated RNA Viral Viral Genes Viral Genome Virus Diseases Western Blotting cell transformation co-infection gammaherpesvirus infected B cell insight lymphoblastoid cell line molecular modeling multicatalytic endopeptidase complex mutant new therapeutic target novel novel therapeutic intervention post-transplant programs recombinant virus recruit response targeted treatment transcription factor transforming virus

项目摘要

Abstract: Immunocompromised HIV-positive patients have serious complications with opportunistic oncogenic viral infections that can lead B-cell lymphomas. Epstein-Barr virus (EBV) and Kaposi’s sarcoma associated virus (KSHV) are two human oncogenic gammaherpesviruses associated with B-cell lymphomas either individually or as co-infections. EBV-associated B-cell lymphomas are established as latency III infection with the major latent genes expressed as well as the small non-coding RNAs. EBV transformed B cells drive latency III, also seen in HIV associated EBV-positive lymphomas. EBV is also associated with other lymphomas including Burkitt’s lymphoma, Hodgkin’s and non-Hodgkin’s lymphoma, and post-transplant and AIDS associated lymphomas in immunocompromised HIV-patients. EBV also efficiently transforms human primary B-cells in vitro, into immortalized lymphoblastoid cell lines (LCLs). These nascent transformed B cells express latent genes, one of which is the Epstein-Barr nuclear antigen EBNA3C, essential for immortalization of B-cells. EBNA3C regulates cellular and viral gene expression through interaction with transcription repressors, and complexes of the mammalian cell cycle which include CyclinA, and components of the SCF proteosome degradation pathway. Our long term goal is to determine the role of EBNA3C in reprogramming viral and infected cell genomes through interactions with the tumor suppressor Rb and the regulatory consequences of these interactions as related to cell survival, cell cycle regulation and proliferation. We will investigate the mechanism of Rb regulation through specific post- translation modifications after infection by EBV, which includes phosphorylation and acetylation important for targeted ubiquitination. We will determine if enhanced phosphorylation/acetylation of Rb occurs through recruitment of CyclinD/Cdk4/6 complexes by EBNA3C important for cell cycle progression. This results in loss of Rb through ubiquitination which leads to cell and viral genome reprogramming by activation of the cellular E2F pathway, cell cycle progression, increased survival and malignant transformation. These studies will examine the role of EBNA3C in regulating the Rb/CyclinD/E2F network important for B-cell immortalization with implications for novel insights into KSHV and EBV contributions to latency III lymphomas in HIV patients.

文摘: